Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCH-NCNP1 in Relapsing Multiple Sclerosis
NCT04211740Phase 2Completed
- Sponsor
- National Center of Neurology and Psychiatry
- Start
- Dec 2019
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OCH in relapsing-remitting multiple sclerosis (RRMS), secondary-progressive multiple sclerosis (SPMS), sponsored by National Center of Neurology and Psychiatry. Started Dec 2019; status: completed.
02
Drugs
OCH
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)secondary-progressive multiple sclerosis (SPMS)
Beyond the preview
Go deeper on NCT04211740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04211740.